# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-019869
Filing Date
2024-04-15
Accepted
2024-04-15 16:35:48
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20023369x2_defa14a.htm | DEFA14A | 7548
2 |  | ny20023369x2-nc_01.jpg | GRAPHIC | 993537
3 |  | ny20023369x2-nc_02.jpg | GRAPHIC | 551696
| Complete submission text file | 0001140361-24-019869.txt |  | 2061702

Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36728 | Film No.: 24845109
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)